NCT00266318View on ClinicalTrials.gov

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Hepatitis C
Interventions
DRUG

Interferon Alfacon-1 and Ribavirin

Trial Locations (1)

10003

Beth Israel Medical Center, New York

Sponsors

Collaborators (1)

InterMune
All Listed Sponsors
collaborator

InterMune

INDUSTRY

lead

Beth Israel Medical Center

OTHER